To move life-changing medical therapies from development to market, biotechnology companies need legal infrastructures that are pragmatic, business-centric, and compliant with the nation’s most complex regulations. Lauren Sullivan has launched several billion-dollar, blockbuster drugs by building that infrastructure. Her decades of experience as in-house counsel for global pharmaceutical companies influence the efficient, comprehensive, and diplomatic counsel biotech innovators rely on to commercialize mission-defining drugs and medical devices.
Lauren’s clients range from biotech startups launching their first products to well-established pharma manufacturers. She shares her clients’ commitment to patients—and is driven by the responsibility of providing real solutions to real people.
Companies gain long-term value from the legal teams and structures Lauren builds to transition therapies to the commercial stage. Her actionable plans integrate all the vital components for product success: FDA and health care compliance, finance, government pricing, antitrust, advertising and promotion, patient support programs, advocacy, and more.
In the era of COVID-19, Lauren has used her signature market-access strategies to support clients’ groundbreaking treatments for the novel coronavirus. Her therapeutics background includes oncology, cellular therapies, gene therapies, antibodies, and other disease treatments. Lauren’s solution-focused negotiation style has earned the trust of her clients. They count on her agile counsel across a dynamic landscape.